280
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Severe presentations and high mortality from SARS-CoV-2 in patients undergoing chimeric antigen receptor (CAR-T) therapy: a UK NCCP analysis

, , , , , , , , , , , , , ORCID Icon, , , & show all
Pages 1980-1984 | Received 17 Dec 2021, Accepted 19 Mar 2022, Published online: 28 Apr 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kathleen P. L. Cheok, Amy A. Kirkwood, Thomas Creasey, Eleni Tholouli, Sridhar Chaganti, Amrith Mathew, Vaishali Dulobdas, David Irvine, Caroline Besley, Lorna Neil, Robert Lown, Tobias Menne, William Townsend, Andrea Kuhnl, Maeve O’Reilly, Robin Sanderson, Emilie Sanchez & Claire Roddie. (2023) Improved COVID-19 outcomes in CAR-T patients in the age of vaccination and preemptive pharmacotherapeutics. Leukemia & Lymphoma 0:0, pages 1-5.
Read now

Articles from other publishers (1)

Kathryn M. Cappell & James N. Kochenderfer. (2023) Long-term outcomes following CAR T cell therapy: what we know so far. Nature Reviews Clinical Oncology.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.